Q2FY24 results: Paytm revenue jumps 32% YoY to ₹2,519 cr
The company’s loss has narrowed by 49% YoY with net income at (₹292 Cr), an improvement of ₹280 Cr YoY ...
Tag: Q2FY24
Alembic Pharmaceuticals receives 6 USFDA approvals during Q2FY24
NE BUSINESS BUREAU MUMBAI, OCT 4 Alembic Pharmaceuticals Limited on Wednesday announced that it has received US Food & Drug ...
